Literature DB >> 11337044

Detection of horses infected naturally with equine infectious anemia virus by nested polymerase chain reaction.

M M Nagarajan1, C Simard.   

Abstract

A nested polymerase chain reaction (PCR) amplifying a region of the gag gene of equine infectious anemia virus (EIAV) was developed for the rapid and direct detection of proviral DNA from the peripheral blood of naturally infected horses and was compared with the Coggins test. DNA prepared from white blood cells of 122 field horses from 15 stables with reported cases of EIAV and one seronegative stable were analysed. Amplifications of expected size fragments were obtained by nested PCR for 88 horses using two different sets of primers targeting the gag region. The specificity of the amplified products was confirmed by hybridization using a digoxigenin-labeled probe. Gag-nested PCR-restriction fragment length polymorphism analysis distinguished two different subtypes of gag gene, A and B. Subtype A was found to be the most prevalent among the infected horses that were tested. The PCR-gag amplified sequence of subtype A shared 84.6% nucleotide and 93% deduced amino acid sequence identities with the prototype Wyoming strain whereas subtype B sequence was almost 100% identical to the prototype. Sequence analysis of gag subtype A suggests the presence of a novel EIAV variant among infected horses in Canada. The nested PCR assay developed in the present study detected more EIAV positive animals and was found as specific as the agar gel immunodiffusion (Coggins) assay and offers great potential a diagnostic test for the detection of EIAV infections in field horses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337044     DOI: 10.1016/s0166-0934(01)00283-x

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  Molecular detection, epidemiology, and genetic characterization of novel European field isolates of equine infectious anemia virus.

Authors:  Katia Cappelli; Stefano Capomaccio; Frank R Cook; Michela Felicetti; Maria Luisa Marenzoni; Giacomo Coppola; Andrea Verini-Supplizi; Mauro Coletti; Fabrizio Passamonti
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

2.  The risk of introduction of equine infectious anemia virus into USA via cloned horse embryos imported from Canada.

Authors:  B D Asseged; T Habtemariam; B Tameru; D Nganwa
Journal:  Theriogenology       Date:  2011-09-29       Impact factor: 2.740

3.  Serosurveillance for equine infectious anaemia in the Ardahan province of Turkey.

Authors:  Harun Albayrak; Emre Ozan
Journal:  Trop Anim Health Prod       Date:  2010-06-03       Impact factor: 1.559

4.  Development, evaluation, and laboratory validation of immunoassays for the diagnosis of equine infectious anemia (EIA) using recombinant protein produced from a synthetic p26 gene of EIA virus.

Authors:  Harisankar Singha; Sachin K Goyal; Praveen Malik; Sandip K Khurana; Raj K Singh
Journal:  Indian J Virol       Date:  2013-08-08

5.  Sero-surveillance of equine infectious anemia virus in equines in India during more than a decade (1999-2012).

Authors:  Praveen Malik; Harisankar Singha; Sachin K Goyal; Sandip K Khurana; Rajender Kumar; Nitin Virmani; Karuppusamy Shanmugasundaram; Shashti B Pandey; Ravi Kant; Birendra K Singh; Raj K Singh
Journal:  Indian J Virol       Date:  2013-07-16

6.  Challenges and proposed solutions for more accurate serological diagnosis of equine infectious anaemia.

Authors:  C J Issel; M T Scicluna; S J Cook; R F Cook; A Caprioli; I Ricci; F Rosone; J K Craigo; R C Montelaro; G L Autorino
Journal:  Vet Rec       Date:  2012-11-16       Impact factor: 2.695

7.  Detection and molecular characterization of equine infectious anemia virus in Mongolian horses.

Authors:  Tumenjargal Sharav; Satoru Konnai; Nyamsuren Ochirkhuu; Erdene Ochir Ts; Hirohisa Mekata; Yoshihiro Sakoda; Takashi Umemura; Shiro Murata; Tungalag Chultemdorj; Kazuhiko Ohashi
Journal:  J Vet Med Sci       Date:  2017-10-11       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.